Skip to main content

A Phase II Study of Neratinib in Metastatic HER2 Non-amplified by HER2 Mutant Breast Cancer

Research Grant
Duke Scholars

Administered By

Duke Cancer Institute

Awarded By

Washington University

Start Date

January 1, 2014

End Date

December 31, 2022
 

Administered By

Duke Cancer Institute

Awarded By

Washington University

Start Date

January 1, 2014

End Date

December 31, 2022